Lab Reagents
Cytomegalovirus Antibody Laboratories manufactures the cytomegalovirus antibody (igg) reagents distributed by Genprice. The Cytomegalovirus Antibody (Igg) reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact cytomegalovirus Antibody. Other Cytomegalovirus products are available in stock. Specificity: Cytomegalovirus Category: Antibody Group: (Igg)
(Igg) information
Cytomegalovirus Antibody / CMV / PP65 |
V2332-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
Cytomegalovirus Antibody / CMV / PP65 |
V2332-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
Cytomegalovirus Antibody / CMV / PP65 |
V2332SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
Cytomegalovirus Antibody / CMV / PP65 |
V2333-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
Cytomegalovirus Antibody / CMV / PP65 |
V2333-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
Cytomegalovirus Antibody / CMV / PP65 |
V2333SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
Cytomegalovirus gB Protein |
20-abx260105 |
Abbexa |
-
EUR 1062.00
-
EUR 410.40
-
EUR 1646.40
|
|
|
Bovine Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-b-48T |
DL Develop |
48T |
EUR 547.2 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Bovine Immunoglobulin G (IgG) in samples from serum, plasma or other biological fluids. |
Bovine Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-b-96T |
DL Develop |
96T |
EUR 708 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Bovine Immunoglobulin G (IgG) in samples from serum, plasma or other biological fluids. |
Canine Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-c-48T |
DL Develop |
48T |
EUR 529.2 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Canine Immunoglobulin G (IgG) in samples from serum, plasma or other biological fluids. |
Canine Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-c-96T |
DL Develop |
96T |
EUR 684 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Canine Immunoglobulin G (IgG) in samples from serum, plasma or other biological fluids. |
Equine Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-Eq-48T |
DL Develop |
48T |
EUR 432 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Equine Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |